HLA-DRB1 and rheumatoid arthritis: While most evidence points towards an absence of effect of RF on DMARD effectiveness (except for some early RA studies), SE-positivity (and especially the HLA-DRB1*04 allele) seems to be associated with a worse response to MTX (non-extendable to persistent remission).